Who are we?

Michael Orme – Founder 

At Signum, Michael focuses on how we are engineering non-living matter – relying on decades of expertise in semiconductors to investigate how we are engineering atoms, photons and quanta into new architectures.

Michael has spent over 40 years analysing technology disruptions. He wrote one of the first books on the microprocessor revolution, called “Micros: a Pervasive Force” (1979), which ran to a Japanese edition. He ran the European operation of what was then Silicon Valley’s premier marketing consultancy Regis McKenna dealing at the top level with clients such as Apple, Intel and Genetech. He ran customer opinion auditing and CIO relations programs for HP in Europe. He is currently working on a book about how upcoming technologies will impact intimate human relations, and is involved in private equity in Kenya.

Eoin Gleeson – Co-Founder, Research Director

Eoin focuses on living matter – genes, cells, microbes, mitochondria, phages, xenobots, transmaterials and synapses – and how we are introducing these biomaterials into humans, animals and crops.

Eoin’s background is in studying complex systems: his postgraduate research focused on simulating crowd behaviour during manias and epidemics. He spent 10 years covering biotech as a journalist: studying a wide range of materials and chemicals: from DNA to sulphuric acid to sewage. At MoneyWeek, he helped build a research business that focused on biotech, R&D and breakthrough technologies. He is currently writing a book on Simulation – and why it heralds an age of very disturbing experiments.

Book Your Free, Informal Consultation

We’ll discuss how we can help you to:
  • Identify any toxic investments that currently exist in your portfolio
  • Pinpoint those companies best positioned to thrive in the current climate
  • Flag up imminent potential risks in the short to mid-term (12 – 24 months)